Everand Logo

Welcome to Everand!

  • STAT

    CAR-T startup Allogene Therapeutics picks up veteran analyst Eric Schmidt as CFO

    by Adam Feuerstein Jun 18, 2018 3 minutes

    Veteran Cowen biotech analyst Eric Schmidt is joining Allogene Therapeutics, the new CAR-T cancer therapy startup, as its chief financial officer.

    The formal announcement was made Monday in a joint statement issued by Allogene and Cowen. Arie Belldegrun, the former Kite Pharma CEO and now co-founder and chairman of Allogene, had been recruiting Schmidt for some time, as previously reported by STAT in May.

    Schmidt is one of Wall Street’s longest-tenured biotech research analysts, widely respected and followed

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
    Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
    Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
    STAT2 min readCrime & Violence
    STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
    A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

    Related